The location of the Liverpool BioCampus in the centre of the city’s Knowledge Quarter encompasses the University of Liverpool, the Royal Liverpool & Broadgreen University Hospitals NHS Trust, the Liverpool School of Tropical Medicine, 2Bio and the Liverpool Science Park.
The BioCampus provides for a concentration and co-location of research, industry and healthcare provision collaborating in health related research and clinical trials, enabling Liverpool to become a centre of global excellence in biomedical sciences.
Royal Liverpool & Broadgreen University Hospitals NHS Trust
The Royal Liverpool & Broadgreen University Hospitals NHS Trust is one of the largest university teaching hospitals in the North West of England. It is comprised of the Royal Liverpool University Hospital, the Liverpool University Dental Hospital and Broadgreen Hospital.
As a centre of excellence for research, development and innovation, the Trust has long standing partnerships with the University of Liverpool, Liverpool John Moores University and the Liverpool School of Tropical Medicine.
The Trust is unique in having both a Biomedical Research Centre for infectious and microbial disease and a Biomedical Research Unit which is the only one of its kind nationally focusing on pancreatic disease. Together with the Cancer Research UK accredited Cancer Research Centre and new Clinical Research Facilities, these have enabled the Trust to develop depth and breadth in research activities.
The Trust offers high quality treatment and diagnosis across more than twenty specialties and hosts several nationally and internationally regarded services, many with leading edge research. These include ophthalmology, pancreatic surgery, gastroenterology, pathology, vascular surgery and interventional radiology. The Trust also provides regional services in nephrology and renal transplantation, nuclear medicine, haematology, dermatology, urology and dental.
The Trust is a major provider of cancer services and is the regional centre for pancreatic, urology, haematology, ocular oncology, testicular, anal, oesophago-gastric, specialist palliative care, specialist radiology and specialist pathology. In addition the Trust offers excellent local cancer treatment services.
University of Liverpool
The University of Liverpool is a member of the UK’s Russell Group of leading research institutions and has an annual turnover of £340 million, including £123 million for research.
With 22,000 students and 153,000 alumni in 159 countries, the University supports more than 5,000 jobs and generates more than £365 million for Liverpool’s economy. The institution works closely with key public agencies to drive the processes of knowledge transfer and business development into the heart of the UK economy and has 560 industry partners.
A truly international institution, Liverpool has established a new university in the World Heritage city of Suzhou near Shanghai, in partnership with Xi’an Jiaotong University – a top 10 university in China, representing a new model for a British operation in Higher Education in China. Xi’an Jiaotong-Liverpool University (XJTLU) is based in Suzhou Industrial Park – one of Asia’s most successful business parks and a hub for foreign investors, attracting 2,100 international organisations, including 76 Fortune 500 companies.
The University is the largest provider of online degree courses in Europe through its partnership with US based Laureate International Universities, one of the world’s largest networks of private higher education institutions. Expansion plans will see the two organisations build further on their close collaboration which already involved the establishment of XJTLU and provision of online degree programmes – with some 3,000 students studying for University of Liverpool degrees around the world.
The University has a successful track record of harnessing its knowledge, expertise and facilities to help commercial and public sector organisations meet the challenges entailed in innovation. In the USA, the University is forging collaborations with a number of universities in and around Atlanta, Georgia, which is also a focus for City Region collaboration around related knowledge transfer and economic development programmes.
Liverpool John Moores University
Liverpool John Moores University (LJMU) has a proven capability and a global reputation for excellence in teaching, research and commercial enterprise and technology transfer. It is the 10th largest university in the UK with 25,900 students in Liverpool plus a further 4,500 students enrolled on accredited LJMU courses around the world. The University has around 2,700 staff and is organised into five academic Faculties with supporting professional services under the remit of six Pro-Vice Chancellors. Annual turnover is approximately £180m. Core research funds are strategically deployed within LJMU to support world leading research and the rate of growth of external research income in recent years remains the highest of North West universities and amongst the highest in the UK overall (well ahead of the sector average of 7%).
As one of the leading research-active contemporary universities in the UK, LJMU can evidence world-leading and internationally-excellent research quality right across the institution. Health and health-related research accounts for two thirds of research activity at LJMU and its Institute for Health Research (IHR) plays a key part in coordinating activity, in strengthening collaborative relationships between researchers in different disciplines, and in facilitating partnerships with external organisations. LJMUs internationally recognised General Engineering Research Institute and Research Institute in Sport and Exercise Sciences work in synergy with the IHR, ensuring that the very applied approach to research adopted across the University results in inter-disciplinary, impactful and groundbreaking outcomes. We see research as pivotal in knowledge transfer engagement with key stakeholders in industry, commerce and throughout the public sector.
Liverpool School of Tropical Medicine
The Liverpool School of Tropical Medicine (LSTM) was the first institution in the world dedicated to research and teaching in tropical medicine. Sir Ronald Ross, Professor of Tropical Medicine at LSTM, became the first British winner of a Nobel Prize for medicine when, in 1902, he was recognised for his discovery that malaria is carried by mosquitoes. LSTM now trains over 500 students a year from more than seventy countries and holds research contracts to the value of £159m. Over the last ten years, annual turnover has increased from £7m to more than £50m and staff numbers have nearly doubled to some 300 people.
LSTM has a strong, internationally excellent research profile with notable strengths in entomological research and drug development. The World Health Organization (WHO), in consultation with the UK government, recently designated LSTM as a WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases. Attracting world-class researchers, scientists and professors, LSTM is an important bioscience asset which significantly contributes to the city region’s knowledge economy.
The new Centre for Tropical and Infectious Diseases (CTID) has considerably expanded research facilities and greatly increased capacity to research and develop new drugs, vaccines and pesticides to combat some of the world’s most devastating diseases. Translational research accounts for an increasing proportion of overall output, bringing research innovation and scientific breakthroughs from the lab to those most in need in the form of new drugs, vaccines, improved vector control products and improved diagnostics and information systems.
MerseyBIO is a specialist bioincubator facility of the University of Liverpool that, together with its sister organisation, Liverpool Science Park, provides laboratory and office facilities to house early-stage life science and technology companies at the heart of Liverpool’s Knowledge Quarter. MerseyBIO lies on the edge of the BioCampus and has 15 laboratory units, currently housing exciting companies developing products and services for the healthcare market.
The companies’ activities are diverse in nature, ranging from novel polymer coatings, organic nanoparticle formulations of drugs and medicinal chemistry services, to nutraceutical product development and complex molecular diagnostic tests for tissue-typing applications. In addition, the companies are supported by a dedicated team, 2Bio, that not only manage the facilities’ operation on a day-to-day basis, but can also provide technology commercialisation, intellectual property strategy and due diligence and market analysis support. MerseyBIO is an integrated bio-business development environment.
Liverpool Science Park
Liverpool Science Park (LSP) provides a home for developing science and knowledge based companies. Its two high-specification facilities offer a combined package of first-class accommodation, business support, and links to the region’s specialist experts. This unique offer means that the facility is drawing in companies from outside the region and abroad as well as retaining home-grown talent who make up an exciting range of knowledge-based sectors – all on the cutting edge of new technology. Partnered with Liverpool John Moores University, the University of Liverpool and Liverpool City Council, LSP provides easy access to the closely located academic research base.
Since it launched in January 2006, LSP has welcomed over 70 companies to the Park. The success of the Park demonstrates the city’s potential as a world-class centre for knowledge enterprise and confirms Liverpool Science Park’s role in redeveloping the city’s wealth and knowledge based economy.
For more information on Liverpool Science Park please visit: